Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
| Autor: | Jeffrey A. Cadeddu, Kirsten L. Greene, Joel B. Nelson, Joann Fontanarosa, Tony Crispino, Danil V. Makarov, Martin G. Sanda, Mary-Ellen Taplin, Erin Kirkby, Laurence Klotz, Howard M. Sandler, Ronald C. Chen, George Rodrigues, Jonathan R. Treadwell, Stephen J. Freedland |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Urology Clinical Decision-Making 030232 urology & nephrology Medical Oncology Severity of Illness Index law.invention Androgen deprivation therapy 03 medical and health sciences Prostate cancer 0302 clinical medicine Quality of life (healthcare) Randomized controlled trial law Health care medicine Humans Societies Medical business.industry Patient Selection Prostate Prostatic Neoplasms Cancer Patient Preference Guideline medicine.disease United States Prostate-specific antigen 030220 oncology & carcinogenesis Family medicine business |
| Zdroj: | Journal of Urology. 199:990-997 |
| ISSN: | 1527-3792 0022-5347 |
| Popis: | This guideline is structured to provide a clinical framework stratified by cancer severity to facilitate care decisions and guide the specifics of implementing the selected management options. The summary presented herein represents Part II of the two-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline discussing risk stratification and care options by cancer severity. Please refer to Part I for discussion of specific care options and outcome expectations and management.The systematic review utilized in the creation of this guideline was completed by the Agency for Healthcare Research and Quality and through additional supplementation by ECRI Institute. This review included articles published between January 2007 and March 2014 with an update search conducted through August 2016. When sufficient evidence existed, the body of evidence for a particular treatment was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. Additional information is provided as Clinical Principles and Expert Opinions (table 2 in supplementary unabridged guideline, http://jurology.com/).The AUA (American Urological Association), ASTRO, and SUO (Society of Urologic Oncology) formulated an evidence-based guideline based on a risk stratified clinical framework for the management of localized prostate cancer.This guideline attempts to improve a clinician's ability to treat patients diagnosed with localized prostate cancer, but higher quality evidence in future trials will be essential to improve the level of care for these patients. In all cases, patient preferences should be considered when choosing a management strategy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|